Ursa Major’s $2.3B SPAC Deal Is a $350M Factory Test

A $2.3 billion valuation is the easy part. Ursa Major now has to prove it can turn $350 million of committed capital into rocket motors fast enough to matter.

Ursa Major’s $2.3B SPAC Deal Is a $350M Factory Test

A $2.3 billion valuation is the easy part. Ursa Major now has to prove it can turn $350 million of committed capital into rocket motors fast enough to matter.

That is the real deal announced on August 25: not another shiny defence-tech listing, but a very expensive test of whether a company can manufacture hard things at wartime speed without setting shareholder money on fire.

The deal: a SPAC, $350 million and no room for theatre

Colorado-based Ursa Major Technologies has agreed to go public through a merger with Bleichroeder Acquisition Corp. III, a SPAC backed by Inflection Point Asset Management. The combined company is expected to trade on Nasdaq under the ticker IPXX after a planned first-quarter 2027 close.

The headline number is a post-transaction equity valuation of roughly $2.3 billion, against a pre-money valuation of about $1.6 billion. The transaction includes at least $350 million in committed PIPE financing, with around $110 million funded at signing. The company may also keep as much as $345 million from the SPAC trust account, but that depends on how many public shareholders redeem their shares.

That last bit matters. A lot.

People see “up to $695 million” and mentally bank the lot. That is amateur-hour thinking. The only money I would treat as properly committed today is the PIPE. The SPAC cash is useful if it arrives, but redemptions are the standard tax on these deals. Until the money is sitting in the account at close, it is potential capital, not factory capacity.

Ursa Major says the funds will expand production of solid rocket motors, its HAVOC missile system, liquid hypersonic engines and space-mobility products. The immediate ambition includes turning its Galeton, Colorado site from a testing operation into a large-scale production campus.

That is why this is worth watching. The company is not selling an app, a marketplace or an AI wrapper with a slick demo. It is selling the ability to make propulsion systems reliably, repeatedly and at scale.

Why Ursa Major matters more than the usual SPAC circus

SPACs earned their rotten reputation honestly. Too many were a shortcut to public markets for businesses that had neither the revenue, the economics nor the maturity to deserve public investors’ money. A PowerPoint deck, heroic forecasts, a bell-ringing ceremony and then—surprise—the shares fell through the floor.

But lumping Ursa Major into the generic SPAC bin would miss the point.

The defence industrial base has a physical production problem. Governments can announce procurement budgets until the cows come home, but announcements do not make rocket motors. You need materials, specialist suppliers, engineers, test infrastructure, manufacturing discipline, quality systems and enough working capital to buy inventory before the customer pays you.

Ursa Major was founded in 2015 and says it has completed more than 5,500 ground tests, accumulated 140,000 seconds of test time and had engines power more than a dozen successful hypersonic missions. Those are company-reported figures, not a guarantee of future production economics—but they are materially different from a startup whose main asset is a slide deck and an optimistic bloke on CNBC.

The company operates in precisely the areas investors now find sexy: hypersonics, missile propulsion, autonomous systems and the broader rush to rebuild Western defence capacity. The catch is that “sexy” is irrelevant once you are trying to make high-performance hardware at scale. Physics does not care about your investor deck. Supply chains do not care about your valuation. A production line does not care how many former generals are on the advisory board.

The overlooked point: this is a working-capital deal

Most commentary on defence technology talks about demand. Demand is not the scarce asset here. The scarce asset is the cash and operational competence required to fulfil demand.

A software company can sell another licence before it hires the next engineer. A propulsion manufacturer often has to spend heavily before it can invoice anyone: long-lead components, propellants, tooling, testing, facilities, labour and compliance. Then it has to survive the inevitable delays that accompany any serious manufacturing ramp.

That is why the $350 million PIPE matters more than the $2.3 billion valuation. The valuation tells you what investors hope Ursa Major becomes. The cash tells you whether management has enough ammunition to make it through the ugly middle bit.

There is a useful lesson here for founders: capital is not just fuel. In a hardware business, capital is part of the product.

If you are making something physical and mission-critical, your balance sheet is part of your credibility. A customer buying propulsion systems is not merely assessing your technology. They are asking whether you can still be alive, solvent and operational when the next order lands.

Ursa Major’s leadership is effectively making this bet: the market will pay for proven production capacity before it is fully built, because waiting for every factory, supplier and process to be perfect would leave them too late to the party.

That may be right. But it is a difficult bet, not a free one.

A $2.3 billion valuation can become a trap

Here is the uncomfortable bit: a large valuation is often sold as validation. It can also become a handcuff.

At a $1.6 billion pre-money valuation, Ursa Major has set a serious benchmark for itself before the public-market listing has even happened. Management now needs to show investors a believable path from testing and early production into recurring, scalable output. Not headlines. Not strategic partnerships dressed up as revenue. Output.

The risk is not that there is no demand for defence systems. The risk is execution.

Can the company hire specialised people quickly without wrecking culture? Can it qualify suppliers? Can it preserve quality while increasing throughput? Can it manage government procurement timelines? Can it avoid building capacity for a demand curve that arrives later than expected? Can it fund working capital without returning to shareholders with the tin cup six months after listing?

These are not trivial questions. In capital-intensive industries, growth can bankrupt you if each additional dollar of revenue consumes too much cash before it produces a return.

And public markets are less patient with industrial growing pains than private investors pretend they are. Private capital can call a delay “strategic sequencing.” Public investors call it a missed quarter, then mark the stock down 30% before lunch.

The contrarian angle: the SPAC may be a feature, not a bug

I generally prefer a proper IPO to a SPAC. The process is cleaner, the price discovery is tougher and the incentives are usually less weird.

But there is a case for this structure here.

Ursa Major is in a capital-heavy category where a conventional IPO may force a company to choose between going public too early or waiting too long to finance production expansion. A SPAC with a large committed PIPE can provide more certainty around capital than an IPO market that suddenly decides it prefers profitable software businesses and safe dividends.

Inflection Point’s involvement matters because it has prior experience taking technology businesses public, including Intuitive Machines and USA Rare Earth. That does not guarantee a good outcome—nothing does—but it is better than handing the keys to a sponsor whose only qualification is being good at launching blank-cheque vehicles.

Still, investors should keep their eyes open. The deal is subject to shareholder, regulatory and other customary approvals. It is expected to close in the first quarter of 2027, not tomorrow. The valuation is an agreement between parties, not a verdict delivered by the market.

The public market will eventually decide what Ursa Major is worth. It will do so based on contracts, production rates, margins, cash burn, delivery performance and credibility. All the stuff that is boring right up until it matters.

What this means for you

If you are a founder, stop treating fundraising as a trophy ceremony. Ask a harder question: what specific operational bottleneck does this money remove?

Write the answer in one sentence. “This capital lets us build the production line, carry inventory for two customers and reduce delivery lead times from X to Y.” If you cannot do that, you probably do not need more money yet—you need a clearer plan.

If you are an operator, learn to separate valuation from resilience. A business valued at $2.3 billion can still be fragile. Look at committed capital, customer concentration, working-capital needs, long-lead supply exposure and the time between cash leaving the bank and cash coming back in.

If you are an investor, do not fall in love with the words “defence tech,” “hypersonic” or “public listing.” Watch the boring scoreboard: funded cash at close, redemptions, production capacity, order conversion, gross margin and the pace of future capital raises.

Ursa Major has a real shot because the problem it is trying to solve is real: the West needs more capacity to build difficult defence hardware. But the winners in this market will not be the firms with the loudest story.

They will be the ones that can make the product, ship the product and get paid without blowing themselves up along the way.

Sources